Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Free Cash Flow (2024 - 2025)

Historic Free Cash Flow for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to -$83.2 million.

  • Kura Oncology's Free Cash Flow fell 9151.47% to -$83.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.1 million, marking a year-over-year change of. This contributed to the annual value of $133.8 million for FY2024, which is 20708.29% up from last year.
  • Kura Oncology's Free Cash Flow amounted to -$83.2 million in Q3 2025, which was down 9151.47% from -$30.2 million recorded in Q2 2025.
  • Kura Oncology's Free Cash Flow's 5-year high stood at $268.8 million during Q4 2024, with a 5-year trough of -$83.2 million in Q3 2025.